Mar 4, 2026 07:30AM
Mar 4, 2026 07:30AM
Feb 18, 2026 06:02AM
Feb 18, 2026 06:00AM
Dec 4, 2025 05:00PM
Dec 4, 2025 05:00PM
Dec 2, 2025 07:01AM CervoMed shows biomarker improvements in dementia trial
Dec 2, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 4, 2025 07:00AM
Nov 4, 2025 07:00AM
Oct 28, 2025 08:03AM
Oct 28, 2025 08:00AM CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Oct 7, 2025 08:01AM
Oct 7, 2025 08:00AM
Sep 17, 2025 07:30AM
Aug 11, 2025 08:00AM
Jul 28, 2025 07:01AM CervoMed reports positive 32-week trial data for dementia drug
Jul 28, 2025 07:00AM
Jun 10, 2025 08:00AM
May 12, 2025 03:57PM
May 12, 2025 08:00AM
Apr 2, 2025 07:00AM
Mar 17, 2025 08:00AM
Mar 11, 2025 08:20AM Brookline Capital Markets Upgrades CervoMed (CRVO) to Buy
Mar 10, 2025 04:05PM
Jan 31, 2025 08:03AM
Jan 31, 2025 08:00AM
Dec 12, 2024 07:00AM
Dec 10, 2024 07:02AM
Dec 10, 2024 07:00AM
Nov 27, 2024 07:02AM CervoMed (CRVO) Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
Nov 27, 2024 07:00AM
Nov 13, 2024 08:00AM
Nov 13, 2024 08:00AM
Nov 12, 2024 07:00AM
Nov 8, 2024 09:55AM
Nov 4, 2024 08:00AM
Oct 29, 2024 08:00AM CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference
Oct 15, 2024 08:00AM
Sep 26, 2024 08:00AM
Aug 22, 2024 08:00AM
Aug 12, 2024 08:00AM
Jul 29, 2024 08:08AM
Jul 29, 2024 08:00AM
Jul 11, 2024 08:51AM CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
Jun 24, 2024 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All